Stille AB Cash Flow Conversion Efficiency
Stille AB cash flow conversion efficiency. Based on the latest financial reports, Stille AB (STIL) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr10.23 Million ≈ $1.10 Million USD) by net assets (Skr692.75 Million ≈ $74.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Stille AB (2008–2024)
Cash flow conversion efficiency of Stille AB from 2008 to 2024. This chart illustrates how Stille AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Stille AB stock quote for real-time trading data and today's change.
Stille AB Cash Flow Conversion Ratio Explained
Stille AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Stille AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stille AB ranked by their cash flow conversion efficiency. Also see market value of Stille AB for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hiron-Trade Investments & Industrial Buildings Ltd
TA:HRON
|
0.015x |
|
Invercap
SN:INVERCAP
|
0.051x |
|
Icelandair Group hf
IC:ICEAIR
|
0.417x |
|
Provident Bancorp Inc
NASDAQ:PVBC
|
0.020x |
|
ICBC Turkey Bank AS
IS:ICBCT
|
1.650x |
|
Standard Biotools Inc
NASDAQ:LAB
|
-0.019x |
|
Zhangjiagang Haiguo New Energy Equipment Manufacturing Co. Ltd.
SHE:301063
|
N/A |
|
Anhui Hyea Aromas Co Ltd
SHE:300886
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Stille AB (2008–2024)
The table below shows the annual cash flow conversion efficiency of Stille AB from 2008 to 2024. Review Stille AB free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr699.40 Million ≈ $75.27 Million |
Skr73.53 Million ≈ $7.91 Million |
0.105x | +78.33% |
| 2023-12-31 | Skr632.25 Million ≈ $68.04 Million |
Skr37.28 Million ≈ $4.01 Million |
0.059x | -64.96% |
| 2022-12-31 | Skr189.81 Million ≈ $20.43 Million |
Skr31.94 Million ≈ $3.44 Million |
0.168x | +242.38% |
| 2021-12-31 | Skr148.10 Million ≈ $15.94 Million |
Skr7.28 Million ≈ $783.23K |
0.049x | -73.45% |
| 2020-12-31 | Skr111.05 Million ≈ $11.95 Million |
Skr20.56 Million ≈ $2.21 Million |
0.185x | -26.11% |
| 2019-12-31 | Skr103.02 Million ≈ $11.09 Million |
Skr25.81 Million ≈ $2.78 Million |
0.251x | +60.36% |
| 2018-12-31 | Skr86.10 Million ≈ $9.27 Million |
Skr13.45 Million ≈ $1.45 Million |
0.156x | -41.28% |
| 2017-12-31 | Skr71.21 Million ≈ $7.66 Million |
Skr18.95 Million ≈ $2.04 Million |
0.266x | -14.58% |
| 2016-12-31 | Skr62.33 Million ≈ $6.71 Million |
Skr19.41 Million ≈ $2.09 Million |
0.311x | +41.95% |
| 2015-12-31 | Skr48.98 Million ≈ $5.27 Million |
Skr10.75 Million ≈ $1.16 Million |
0.219x | +724.50% |
| 2014-12-31 | Skr38.45 Million ≈ $4.14 Million |
Skr-1.35 Million ≈ $-145.39K |
-0.035x | +15.76% |
| 2013-12-31 | Skr41.35 Million ≈ $4.45 Million |
Skr-1.73 Million ≈ $-185.64K |
-0.042x | -122.73% |
| 2012-12-31 | Skr38.06 Million ≈ $4.10 Million |
Skr6.98 Million ≈ $751.59K |
0.183x | +583.00% |
| 2011-12-31 | Skr40.16 Million ≈ $4.32 Million |
Skr1.08 Million ≈ $116.12K |
0.027x | -22.07% |
| 2010-12-31 | Skr41.02 Million ≈ $4.41 Million |
Skr1.41 Million ≈ $152.17K |
0.034x | +265.35% |
| 2009-12-31 | Skr38.23 Million ≈ $4.11 Million |
Skr-797.00K ≈ $-85.77K |
-0.021x | -121.78% |
| 2008-12-31 | Skr34.03 Million ≈ $3.66 Million |
Skr3.26 Million ≈ $350.51K |
0.096x | -- |
About Stille AB
Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascu… Read more